|
1.
|
Hughes DJ, Marendy EM, Dickerson CA, Yetming KD, Sample CE, Sample JT. Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency. J Virol. 2012 Jan; 86(2):1034-45.
|
|
|
|
|
2.
|
Hughes DJ, Dickerson CA, Shaner MS, Sample CE, Sample JT. trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency. J Virol. 2011 Nov; 85(21):11435-47.
|
|
|
|
|
3.
|
Lockey TD, Zhan X, Surman S, Sample CE, Hurwitz JL. Epstein-Barr virus vaccine development: a lytic and latent protein cocktail. Front Biosci. 2008; 13:5916-27.
|
|
|
|
|
4.
|
Long SM, Sample CE. EBV-associated diseases in the AIDS patient. Cancer Treat Res. 2007; 133:163-83.
|
|
|
|
|
5.
|
Jiménez-Ramírez C, Brooks AJ, Forshell LP, Yakimchuk K, Zhao B, Fulgham TZ, Sample CE. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter. J Virol. 2006 Nov; 80(22):11200-8.
|
|
|
|
|
6.
|
Zhao B, Dalbiès-Tran R, Jiang H, Ruf IK, Sample JT, Wang F, Sample CE. Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses. J Virol. 2003 May; 77(10):5639-48.
|
|
|
|
|
7.
|
Ruvolo V, Navarro L, Sample CE, David M, Sung S, Swaminathan S. The Epstein-Barr virus SM protein induces STAT1 and interferon-stimulated gene expression. J Virol. 2003 Mar; 77(6):3690-701.
|
|
|
|
|
8.
|
Gottschalk S, Ng CY, Perez M, Smith CA, Sample C, Brenner MK, Heslop HE, Rooney CM. An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs. Blood. 2001 Feb 15; 97(4):835-43.
|
|
|
|
|
9.
|
Dalbiès-Tran R, Stigger-Rosser E, Dotson T, Sample CE. Amino acids of Epstein-Barr virus nuclear antigen 3A essential for repression of Jkappa-mediated transcription and their evolutionary conservation. J Virol. 2001 Jan; 75(1):90-9.
|
|
|
|
|
10.
|
Zhao B, Sample CE. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site. J Virol. 2000 Jun; 74(11):5151-60.
|
|
|
|
|
11.
|
Parfenov VN, Davis DS, Pochukalina GN, Sample CE, Murti KG. Nuclear bodies of stage 6 oocytes of Rana temporaria contain nucleolar and coiled body proteins. Exp Cell Res. 1996 Nov 1; 228(2):229-36.
|
|
|
|
|
12.
|
Zhao B, Marshall DR, Sample CE. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa. J Virol. 1996 Jul; 70(7):4228-36.
|
|
|
|
|
13.
|
Razzouk BI, Srinivas S, Sample CE, Singh V, Sixbey JW. Epstein-Barr Virus DNA recombination and loss in sporadic Burkitt's lymphoma. J Infect Dis. 1996 Mar; 173(3):529-35.
|
|
|
|
|
14.
|
Marshall D, Sample C. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. J Virol. 1995 Jun; 69(6):3624-30.
|
|
|
|
|
15.
|
Wrightham MN, Stewart JP, Janjua NJ, Pepper SD, Sample C, Rooney CM, Arrand JR. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology. 1995 Apr 20; 208(2):521-30.
|
|
|
|
|
16.
|
Parfenov VN, Davis DS, Pochukalina GN, Sample CE, Bugaeva EA, Murti KG. Nuclear actin filaments and their topological changes in frog oocytes. Exp Cell Res. 1995 Apr; 217(2):385-94.
|
|
|
|
|
17.
|
Sample C, Parker B. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins. Virology. 1994 Dec; 205(2):534-9.
|
|
|
|
|
18.
|
Sample J, Henson EB, Sample C. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J Virol. 1992 Aug; 66(8):4654-61.
|
|
|
|
|
19.
|
Sample J, Brooks L, Sample C, Young L, Rowe M, Gregory C, Rickinson A, Kieff E. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci U S A. 1991 Jul 15; 88(14):6343-7.
|
|
|
|
|
20.
|
Sample C, Kieff E. Molecular basis for Epstein-Barr virus induced pathogenesis and disease. Springer Semin Immunopathol. 1991; 13(2):133-46.
|
|
|
|
|
21.
|
Petti L, Sample C, Kieff E. Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins. Virology. 1990 Jun; 176(2):563-74.
|
|
|
|
|
22.
|
Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol. 1990 May; 64(5):2309-18.
|
|
|
|
|
23.
|
Ness GC, Sukalski KA, Sample CE, Pendleton LC, McCreery MJ, Nordlie RC. Radiation inactivation analysis of rat liver microsomal glucose-6-phosphatase. J Biol Chem. 1989 May 5; 264(13):7111-4.
|
|
|
|
|
24.
|
Sanke T, Bell GI, Sample C, Rubenstein AH, Steiner DF. An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing. J Biol Chem. 1988 Nov 25; 263(33):17243-6.
|
|
|
|
|
25.
|
Sample CE, Steiner DF. Tissue-specific binding of a nuclear factor to the insulin gene promoter. FEBS Lett. 1987 Oct 5; 222(2):332-6.
|
|
|
|
|
26.
|
Sample CE, Pendleton LC, Ness GC. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels by L-triiodothyronine. Biochemistry. 1987 Feb 10; 26(3):727-31.
|
|
|
|
|
27.
|
Sample CE, Ness GC. Regulation of the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase by insulin. Biochem Biophys Res Commun. 1986 May 29; 137(1):201-7.
|
|
|
|
|
28.
|
Ness GC, Sample CE, Smith M, Pendleton LC, Eichler DC. Characteristics of rat liver microsomal 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Biochem J. 1986 Jan 1; 233(1):167-72.
|
|
|
|
|
29.
|
Ness GC, McCreery MJ, Sample CE, Smith M, Pendleton LC. Sulfhydryl/disulfide forms of rat liver 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Biol Chem. 1985 Dec 25; 260(30):16395-9.
|
|
|
|
|
30.
|
Phillips CE, Ness GC. Topography of rat liver microsomal 3-hydroxy-3-methylglutaryl coenzyme A reductase. Biochem Biophys Res Commun. 1984 Mar 15; 119(2):772-8.
|
|
|
|